Free
E-newsletter
Subscribe to Housecall
Our weekly general interest
e-newsletter keeps you up to date
on a wide variety of health topics.
Mayo Clinic Housecall
Stay up to date on the latest health information.
What you get
- Free weekly e-newsletter
- Mayo Clinic expertise
- Recipes, tools and other helpful information
- We do not share your e-mail address
Eribulin (Intravenous Route)
Drug Information provided by: MicromedexUS Brand Names
|
Description
Eribulin belongs to the group of medicines called antineoplastics (cancer medicines). It is used to treat metastatic (cancer that has already spread) breast cancer. This medicine is used in patients who have already received at least two types of cancer medicines.
Eribulin interferes with the growth of cancer cells, which are eventually destroyed. Since the growth of normal body cells may also be affected by this medicine, other side effects may occur. Some of these may be serious and must be reported to your doctor right away. Some unwanted effects may not be serious but may cause concern. Some of the unwanted effects do not occur until months or years after the medicine is used.
Before you begin treatment with eribulin, you and your doctor should talk about the benefits of this medicine as well as the risks.
This medicine is to be administered only by or under the immediate supervision of your doctor.
This product is available in the following dosage forms:
- Solution
Find Mayo Clinic on